-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Iu+5EyDgwFcMOpoX2Nrxze1CCZfdFK2oV5R+kGlmWSsjnxlhBPvDMee1NvPP3hg0 8lrMMxUovUZC4pPfHAzDnQ== 0000732485-05-000048.txt : 20050715 0000732485-05-000048.hdr.sgml : 20050715 20050715112556 ACCESSION NUMBER: 0000732485-05-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050714 FILED AS OF DATE: 20050715 DATE AS OF CHANGE: 20050715 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARPENTER ROBERT J CENTRAL INDEX KEY: 0001021046 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 05956214 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 car213.xml X0202 4 2005-07-14 0 0000732485 GENZYME CORP GENZ 0001021046 CARPENTER ROBERT J GENZYME CORPORATION 500 KENDALL STREET CAMBRIDGE MA 02142 1 0 0 0 Genzyme common stock (GENZ) 2005-07-14 2005-07-14 4 M 0 5000 15.13 A 45000 D Genzyme common stock (GENZ) 2005-07-14 2005-07-14 4 M 0 5000 15.13 A 50000 D Genzyme common stock (GENZ) 2005-07-14 2005-07-14 4 S 0 5000 64.00 D 45000 D Genzyme common stock (GENZ) 2005-07-14 2005-07-14 4 S 0 5000 65.00 D 40000 D Genzyme common stock (GENZ) 2005-07-15 2005-07-15 4 M 0 4000 15.13 A 44000 D Genzyme common stock (GENZ) 2005-07-15 2005-07-15 4 S 0 4000 66.00 D 40000 D Genzyme common stock (GENZ) 1758 I By 401(k) Genzyme DOP stock option (right to buy) 15.13 2005-07-14 2005-07-14 4 M 0 5000 0 D 1997-05-29 2006-05-16 Genzyme common stock (GENZ) 5000 9000 D Genzyme DOP stock option (right to buy) 15.13 2005-07-14 2005-07-14 4 M 0 5000 0 D 1997-05-29 2006-05-16 Genzyme common stock (GENZ) 5000 4000 D Genzyme DOP stock option (right to buy) 15.13 2005-07-15 2005-07-15 4 M 0 4000 0 D 1997-05-29 2006-05-16 Genzyme common stock (GENZ) 4000 0 D The sales reported were effected pursuant to a Rule 10b5-1 trading plan adpoted by the reporting person on June 15, 2005. The exercise of this stock option included a distribution of an additional 2 shares of Genzyme common stock. These stock options were entitled to receive a distribution of shares of Tissue Repair common stock that was paid on July 22, 1997 to Genzyme stockholders at a rate of 0.015. In connection with the formation of Genzyme Biosurgery in December 2000, shares of Genzyme Tissue Repair were converted into shares of Genzyme Biosurgery at a rate of 0.3352. In connection with the exchange of Genzyme Biosurgery stock into Genzyme stock on June 30, 2003, distributions of the Genzyme Biosurgery stock are exchanged into Genzyme stock at a rate of 0.04945. Options vest in 1/3 annual increments on the dates of the next three annual meetings of shareholders following the original date of grant. By: Susan P. Cogswell, Attorney-in-Fact 2005-07-15 -----END PRIVACY-ENHANCED MESSAGE-----